Depending on the tumor type, Dkk1 upregulation has a conflicting roleDkk1 overexpression is involved in the invasiveness of pancreatic ductal adenocarcinoma [67], while in breast cancer, it is responsible for the lower proliferation ability via keeping the Wnt/β-catenin pathway under control [68]. Here, DKK1 is linked to neoplasm.